Amgen (AMGN) stock slid more than 4.5% at the start of Wednesday trading after the pharmaceutical giant reported the results of several drug trials.
Amgen (AMGN) stock slid more than 4.5% at the start of Wednesday trading after the pharmaceutical giant reported the results of several drug trials.
State TV in China reported that Ministry of Finance and Ministry of...
ByglobalreutersSeptember 26, 2024Since July of this year, the oil market has struggled to regain...
ByglobalreutersSeptember 26, 2024US initial jobless claims 218K versus 225K estimateUS Q2 final GDP +3.0%...
ByglobalreutersSeptember 26, 2024Federal Reserve Board Governor Lisa Cook is speaking at 2200 GMT, which...
ByglobalreutersSeptember 26, 2024
Leave a comment